These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4740776)

  • 1. [Kinetics of the inhibition of xanthine oxidase (EC 1.2.3.2) by 6-(imidazole-2-thio)purine].
    Niebch G; Schneider F
    Arzneimittelforschung; 1973 Jun; 23(6):880-1. PubMed ID: 4740776
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of xanthine oxidase by cytokinins and related substances.
    Sheu SY; Lin YC; Chiang HC
    Anticancer Res; 1996; 16(6B):3571-6. PubMed ID: 9042223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relation of the nitrate reductase activity of xanthine oxidase to the oxidase and dehydrogenase forms of the enzyme].
    Sergeev NS; Ananiadi LI; L'vov NP; Kretovich VL
    Dokl Akad Nauk SSSR; 1983; 272(4):984-6. PubMed ID: 6580130
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis and biological evaluation of new imidazole, pyrimidine, and purine derivatives and analogs as inhibitors of xanthine oxidase.
    Biagi G; Costantini A; Costantino L; Giorgi I; Livi O; Pecorari P; Rinaldi M; Scartoni V
    J Med Chem; 1996 Jun; 39(13):2529-35. PubMed ID: 8691450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of xanthine oxidase by hydroxylated anthraquinones and related compounds.
    Sheu SY; Chiang HC
    Anticancer Res; 1997; 17(5A):3293-7. PubMed ID: 9413162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The screening and characterization of 6-aminopurine-based xanthine oxidase inhibitors.
    Hsieh JF; Wu SH; Yang YL; Choong KF; Chen ST
    Bioorg Med Chem; 2007 May; 15(10):3450-6. PubMed ID: 17379526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xanthine oxidase inhibition: effect of an N-alkyl substituent on C-2 of the nucleus of 8-azahypoxanthine.
    Biagi G; Giorgi I; Livi O; Scartoni V; Lucacchini A
    Farmaco; 1989 Sep; 44(9):843-9. PubMed ID: 2604836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Synthesis, structure and biochemical properties of 6-(imidazole-2-thio)purine nucleosides].
    Hopf U; Niebch G; Schneider F
    Hoppe Seylers Z Physiol Chem; 1972 Apr; 353(4):654-66. PubMed ID: 5066157
    [No Abstract]   [Full Text] [Related]  

  • 9. Oxidation of 7-methylguanine by human xanthine oxidase.
    Skupp S; Ayvazian JH
    J Lab Clin Med; 1969 Jun; 73(6):909-16. PubMed ID: 5815015
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiple phases in the reduction of xanthine oxidase by substrates.
    Swann JC; Bray RC
    Eur J Biochem; 1972 Apr; 26(3):407-15. PubMed ID: 4338679
    [No Abstract]   [Full Text] [Related]  

  • 11. [The quaternary structure of milk xanthine oxidase. Dissociation in sodium dodecyl sulfate].
    Nagler LG; Vartanian LS
    Biokhimiia; 1973; 38(3):561-7. PubMed ID: 4801600
    [No Abstract]   [Full Text] [Related]  

  • 12. The chemistry of the inhibition of blood xanthine oxidase by -SH reagents.
    Affonso OR; Mitidieri E
    An Acad Bras Cienc; 1976; 48(3):591-5. PubMed ID: 1032094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-Hydroxyguanidine compound 1-(3,4-dimethoxy- 2-chlorobenzylideneamino)-3-hydroxyguanidine inhibits the xanthine oxidase mediated generation of superoxide radical.
    Dambrova M; Baumane L; Kiuru A; Kalvinsh I; Wikberg JE
    Arch Biochem Biophys; 2000 May; 377(1):101-8. PubMed ID: 10775447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human xanthine oxidase changes its substrate specificity to aldehyde oxidase type upon mutation of amino acid residues in the active site: roles of active site residues in binding and activation of purine substrate.
    Yamaguchi Y; Matsumura T; Ichida K; Okamoto K; Nishino T
    J Biochem; 2007 Apr; 141(4):513-24. PubMed ID: 17301077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Regulation of purine metabolism and its modification by drugs].
    Müller MM; Kaiser E
    Dtsch Med Wochenschr; 1975 Jan; 100(5):198-204. PubMed ID: 1112235
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of xanthine oxidase by synthetic cytokinin analogues.
    Sheu SY; Lin YC; Chiang HC
    Anticancer Res; 1997; 17(2A):1043-9. PubMed ID: 9137447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of xanthine oxidase by benzothiazinone analogues.
    Sheu SY; Lin CY; Wu JD; Chiang HC
    Anticancer Res; 1999; 19(1A):119-23. PubMed ID: 10226532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase.
    Takano Y; Hase-Aoki K; Horiuchi H; Zhao L; Kasahara Y; Kondo S; Becker MA
    Life Sci; 2005 Mar; 76(16):1835-47. PubMed ID: 15698861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Behavior of some purine derivatives towards xanthine oxidase].
    Werner D; Kapoor NK
    Naturwissenschaften; 1966 Jun; 53(12):308-9. PubMed ID: 5986213
    [No Abstract]   [Full Text] [Related]  

  • 20. [Detection and characterization of several drugs derived from purine by thin layer chromatography].
    Poey J; Denine R; Merad-Boudia R; Mrabet N
    Eur J Toxicol; 1971; 4(4):341-4. PubMed ID: 5150094
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.